Psoralen Derivatives with Enhanced Potency

Area of Science:

• Medicinal Chemistry
• Natural Products
• Photochemistry

Background:

• Psoralens are furocoumarin natural products known for DNA intercalation and covalent adduct formation upon UV activation.
• Psoralen's efficacy is established in treating conditions like psoriasis, vitiligo, graft-versus-host disease, and cutaneous T-cell lymphoma.
• The therapeutic relevance necessitates the development of more potent psoralen derivatives.

Purpose of the Study:

• To synthesize a library of novel psoralen derivatives with enhanced potency.
• To evaluate the cytotoxicity and DNA adduct formation of these novel compounds.
• To establish structure-activity relationships for optimizing psoralen-based therapeutics.

Main Methods:

• Synthesis of a library comprising 73 novel psoralen compounds.
• Screening for cytotoxicity by measuring the reduction in cell proliferation.
• Analysis of DNA adduct formation using MALDI-TOF MS.
• Correlation of structural modifications with observed biological activity.

Main Results:

• Identification of two novel psoralen derivatives exhibiting greater cytotoxicity than the potent 4'-aminomethyl-4,5',8-trimethylpsoralen (AMT).
• A strong correlation was observed between enhanced DNA binding affinity and increased cytotoxicity for most novel psoralens.
• Potent derivatives typically feature positively charged substituents, suggesting increased DNA affinity and intercalation.

Conclusions:

• The study provides a rational strategy for optimizing psoralen derivatives to maximize their therapeutic potential.
• Novel psoralens with enhanced potency and DNA binding capabilities have been developed.
• Structure-activity insights offer opportunities to further investigate psoralen's mechanism of action.